4 ways to Improve Clinical Data Quality in the Digital Era
Clinical Data Quality is of the utmost importance when working towards a regulatory submission. These 4 methods are a must have in the new digital era.
Clinical Data Quality is of the utmost importance when working towards a regulatory submission. These 4 methods are a must have in the new digital era.
Our statisticians discuss Real World Evidence and its importance on drug development, and how it can be used during COVID-19.
RTOR can reduce the approval time for Oncology Clinical Trials without affecting the safety and effectiveness of the treatment.
Patients who survive COVID‑19 may suffer lasting lung damage. This blog explores Pulmonary fibrosis in COVID-19 and Respiratory Clinical Trial Designs.
Regulatory Writing is used to create a variety of clinical documents. Such clinical trial documentation includes clinical study reports. Learn more
Remote monitoring in clinical trials has never been so popular. This article explains a risk-based approach to remote monitoring and remote SDV
This blog provides a background on CDISC SDTM Standards, and the advantages of SDTM's application
An Adaptive Randomization method based on a Patient's Characteristics used in phase 2 and phase 3 clinical trials that focuses on personalizing medication for rare diseases and adaptive trial design.
As industry regulators and study participants seek disclosure of information in clinical trials, medical writers are creating Plain Language Summaries
Stay up to date with the latest statistics and scientific resources on the novel coronavirus (covid-19) pandemic